Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 25, 2021 at 04:35 am EDT
Share
Tibet Cheezheng Tibetan Medicine Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,189.27 million compared to CNY 1,021.96 million a year ago. Revenue was CNY 1,189.27 million compared to CNY 1,021.96 million a year ago. Net income was CNY 647.39 million compared to CNY 324 million a year ago. Basic earnings per share from continuing operations was CNY 1.2247 compared to CNY 0.6127 a year ago. Diluted earnings per share from continuing operations was CNY 1.2247 compared to CNY 0.6127 a year ago.
Tibet Cheezheng Tibetan Medicine Co., Ltd is a China-based company, principally engaged in the research, development, manufacture and distribution of Tibetan medicines. The Company primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The Company's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The Company distributes its products within domestic market and to overseas markets.
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. 